From: Predictors of short-term response and the role of heavy alcohol use in treatment of depression
All patients (n = 150) | Patients without AUD (n = 100) | Patients with AUD (n = 50) | ||||
---|---|---|---|---|---|---|
Nagelkerke R Square 0.250 | Nagelkerke R Square = 0.257 | Nagelkerke R Square = 0.582 | ||||
OR (95% CI) | p | OR (95% CI) | p | OR (95%CI) | p | |
Age | 1.02 (0.98–1.05) | 0.333 | 1.00 (0.96–1.04) | 0.933 | 1.06 (0.99–1.14) | 0.093 |
Gender3 | 0.51 (0.23–1.12) | 0.094 | 0.56 (0.18–1.74) | 0.320 | 0.41 (0.09–1.94) | 0.263 |
Baseline MADRS | 1.10 (1.02–1.18) | 0.008 | 1.12 (1.01–1.25) | 0.027 | 1.11 (0.98–1.25) | 0.093 |
Baseline AUDIT-C4 | 1.16 (1.03–1.31) | 0.013 | 1.11 (0.89–1.38) | 0.371 | 1.54 (1.04–2.27) | 0.029 |
Dose of antidepressants5 | 0.99 (0.97–1.01) | 0.172 | 0.98 (0.95-1.00) | 0.066 | 1.01 (0.98–1.05) | 0.493 |
Use of antipsychotics6 | 0.17 (0.07–0.44) | < 0.001 | 0.20 (0.06–0.67) | 0.010 | 0.12 (0.02–0.60) | 0.011 |
Any anxiety disorder | 0.50 (0.22–1.14) | 0.099 | 0.40 (0.15–1.08) | 0.070 | 1.32 (0.30–5.87) | 0.712 |